Tokyo, Japan

Muneyoshi Kato

This inventor holds 1 USPTO granted patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Muneyoshi Kato. Retrieved from https://idiyas.com/inventor/muneyoshi-kato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Muneyoshi Kato: Innovator in Liposome Eye Drops

Introduction

Muneyoshi Kato is a prominent inventor based in Tokyo, Japan. He is known for his innovative contributions to the field of pharmaceuticals, particularly in the development of liposome eye drops. His work has significantly impacted the way eye care products are formulated and delivered.

Latest Patents

Muneyoshi Kato holds a patent for liposome eye drops, which represents a breakthrough in ocular drug delivery systems. This invention aims to enhance the effectiveness and comfort of eye treatments, providing patients with improved therapeutic options.

Career Highlights

Kato is associated with Taisho Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His role at the company has allowed him to focus on research and development, contributing to advancements in medical technology.

Collaborations

Throughout his career, Muneyoshi Kato has collaborated with notable colleagues, including Tomohiro Ohtsuki and Fuminobu Egami. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Muneyoshi Kato's work in developing liposome eye drops showcases his dedication to improving healthcare solutions. His contributions to the pharmaceutical industry continue to influence the field and enhance patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…